Skip to main content

Publishing – Getting the Word Out to Doctors

  • Chapter
It's Great! Oops, No It Isn't
  • 1639 Accesses

The lifeblood of scientific discovery is information. Unless research findings are published and reach the medical community, they are of little value. However, there are problems with the present method of publishing medical research results. Peer review, a process by which experimenters review each other's work in order to weed out poor research, may not catch important errors. The results from some clinical research trials with negative findings may not be published and that also represents a serous problem. Paxil, a drug that some believe leads to juvenile suicides is used to illustrate this issue. A major Paxil trial with a positive result was published and presented at medical meetings, but a similar trial with a negative result ended up with no publication. The case illustrates that a drug's safety and efficacy problems can be deliberately hidden from the medical profession and the public. There are therefore calls for a clinical trial registry, which would contain the results of all clinical research investigations whether or not published in a journal. In addition, an innovative plan by faculty members of the London School of Hygiene and Tropical Medicine is used to suggest a radically way to change the current publication system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Chapter 18 — Publishing

Cited References

  1. Altman D, Goodman S, Schroter S. How statistical expertise is used in medical research. JAMA 2002:287;2817–2820.

    Article  PubMed  Google Scholar 

  2. Chan A, Altman D. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. Br Med J 2005:330;753.

    Article  Google Scholar 

  3. Chan A, Hróbjartsson A, Haahr M, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004:291;2457–2465.

    Article  PubMed  CAS  Google Scholar 

  4. Diamond G, Bax L, Kaul S. Uncertain effects of Rosiglitazone on the risk for myocardial infarction and cardiovascular death. Ann Intern Med. Epub http://www.annals.org/cgi/content/abstract/0000605—200710160—00182v1 Aug 7, 2007.

  5. Home P, Pocock S, Beck-Nielsen H. Rosiglitazone evaluated for cardiovascular outcomes — an interim analysis. New Engl J Med 2007:357;28–38.

    Article  PubMed  CAS  Google Scholar 

  6. Kassirer J. Reflections on medical journals: has progress made them better? Ann Intern Med 2002:137;46–48.

    PubMed  Google Scholar 

  7. May G, DeMets D, Friedman L, et al. The randomized clinical trial: bias in analysis. Circulation 1981:64;669–673.

    PubMed  CAS  Google Scholar 

  8. Nissen S, Wolski K. Effect of Rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New Engl J Med 2007:356;2457–2471.

    Article  PubMed  CAS  Google Scholar 

  9. Science and technology: sloppy stats shame science. The Economist June 5, 2004:371;79.

    Google Scholar 

  10. Smith R, Roberts I. Patient safety requires a new way to publish clinical trials. PLoS Clin Trials 2006:1;e6.

    Article  PubMed  Google Scholar 

General References

  1. Altman D. Poor-quality medical research: what can journals do? JAMA 2002:287;2765–2767.

    Article  PubMed  Google Scholar 

  2. Altman L. When peer review produces unsound science. New York Times June 11, 2002:F6.

    Google Scholar 

  3. Altman L. The doctor's world: for science's gatekeepers, a credibility gap. New York Times May, 2006:F1.

    Google Scholar 

  4. De Angelis C, Drazen J, Frizelle F, et al. Clinical trial registration: a statement from the nternational Committee of Medical Journal Editors. New Engl J Med 2004:351;1250–1251

    Article  PubMed  Google Scholar 

  5. Editorial. For truth in drug trial reporting. New York Times June 20, 2004:412.

    Google Scholar 

  6. Editorial. Manipulating a journal article. New York Times Dec 11, 2005 p 4.11.

    Google Scholar 

  7. Fontanarosa P, Flanagin A, DeAngelis C. Reporting conflicts of interest, financial aspects of esearch, and role of sponsors in funded studies. JAMA 2005:294;110–111.

    Article  PubMed  CAS  Google Scholar 

  8. Gorner P. Medical studies make news, worthy or not; researchers see flaws in coverage. Chicago ribune June 5, 2002:110.

    Google Scholar 

  9. Harris G. New York State official sues drug maker over test data. New York Times June 3, 2004:A1.

    Google Scholar 

  10. Jefferson T. Effects of editorial peer review: a systematic review. JAMA 2002:287;2784–2786.

    Article  PubMed  Google Scholar 

  11. Korn D, Ehringhaus S. Principles for strengthening the integrity of clinical research. PLoS Clin Trials 2006:1;e1.

    Article  PubMed  Google Scholar 

  12. Meier B. Contracts keep drug research out of reach. New York Times Nov 29, 2004;A1.

    Google Scholar 

  13. Meier B. Two studies, two results, and a debate over a drug. New York Times June 3, 2004:C1.

    Google Scholar 

  14. Rennie D. Fourth international congress on peer review in biomedical publications. JAMA 2002:287;2759–2760.

    Article  PubMed  Google Scholar 

  15. Specter M. Quality control of published medical studies debated. Washington Post May 15, 1989:A20.

    Google Scholar 

  16. Steinbrook R. Registration of clinical trials — voluntary or mandatory? New Engl J Med 2004:351;1820–1822.

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media B.V

About this chapter

Cite this chapter

(2009). Publishing – Getting the Word Out to Doctors. In: It's Great! Oops, No It Isn't. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8907-7_18

Download citation

Publish with us

Policies and ethics